Influence of p53 on Herpes Simplex Virus Type 1 Vectors for Cancer Gene Therapy

Journal of Gastrointestinal Surgery

Volumn 3, Issue 1, 1999, Pages 34-38

  Yoon, Sam S ^a   Carroll, Nancy M ^a   Chiocca, E Antonio ^a   Tanabe, Kenneth K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Colorectal cancer; Gene therapy; HSV 1; p53

Indexed keywords

ANIMAL; ARTICLE; CELL CULTURE; CERCOPITHECUS; COLORECTAL TUMOR; GENE EXPRESSION REGULATION; GENE THERAPY; GENE VECTOR; GENETICS; HERPES SIMPLEX VIRUS 1; HUMAN; LIVER TUMOR; METASTASIS; PATHOLOGY; TUMOR SUPPRESSOR GENE;

ANIMALS; CERCOPITHECUS AETHIOPS; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE THERAPY; GENES, P53; GENETIC VECTORS; HERPESVIRUS 1, HUMAN; HUMANS; LIVER NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0032600336     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(99)80005-5     Document Type: Article

References (25)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics 1998. CA Cancer J Clin 1988;48:6-29.
2. Millikan KW, Staren ED, Doolas A. Invasive therapy of metastatic colorectal cancer to the liver. Surg Clin North Am 1997;77:27-48.
3. Taylor M, Forster J, Langer B, Taylor BR, Greig PD, Mahut C. A study of prognostic factors for hepatic resection for colorectal metastases. Am J Surg 1997;173:467-471.
4. Carroll NM, Chiocca EA, Takahashi K, Tanabe KK. Enhancement of gene therapy specificity for diffuse colon carcinoma liver metastases with recombinant herpes simplex virus. Ann Surg 1996;224:323-329.
5. Carroll NM, Chiocca EA, Tanabe KK. Gene transfer and cytotoxicity mediated by recombinant herpes simplex virus vectors. Gastroenterology 1996(Suppl);110:A1377.
6. Carroll NM, Chiocca EA, Tanabe KK. The effect of ganciclovir on herpes simplex virus-mediated oncolysis. J Surg Res 1997;69:413-417.
7. Yoon SS, Carroll NM, Chiocca EA, Tanabe KK. Cancer gene therapy using a replication-competent herpes simplex virus type 1 vector. Ann Surg 1998;228:366-374.
8. Bennett WP. p53 alterations in progenitor lesions of the bronchus, esophagus, oral cavity, and colon. Cancer Detect Prev 1995;19:503-511.
9. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-331.
10. Ko LJ, Prives C. p53: Puzzle and paradigm. Genes Dev 1996;10:1054-1072.
11. Kao CC, Yew PR, Berk AJ. Domains required for the in vitro association between the cellular p53 and the adenovirus 2 E1B 55K proteins. Virology 1990;179:806-814.
12. Yew PR, Berk AJ. Inhibition of p53 transactivation required for transformation, by adenovirus early 1B protein. Nature 1992;357:82-85.
13. Scheffner M, Huibregtse JM, Vierstra RD, Howley PM. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993;75:495-505.
14. Wilcock D, Lane DP. Localization of p53, retinoblastoma and host replication proteins at sites of viral replication in herpes-infected cells. Nature 1991;349:429-431.
15. Yuan J, Liu B, Lee H, Shaw Y, Chiou S, Chang W, Lai M. Release of the p53-induced repression on thymidine kinase promoter by single p53-binding sequence. Biochem Biophy Res Comm 1993;191:662-668.
16. Subler MA, Martin DW, Deb S. Inhibition of viral and cellular promoters by human wild-type p53. J Virol 1992;66:4757-4762.
17. Lowe SW. Cancer therapy and p53. Curr Opin Oncol 1995; 7:547-553.
18. Radinsky R, Fidler IJ, Price JE, Esumi N, Tsan R, Petty CM, Bucana CD, Bar-Eli M. Terminal differentiation and apoptosis in experimental lung metastases of human osteogenic sarcoma cells by wild type p53. Oncogene 1994;9:1877-1883.
19. Baker SJ, Marknwitz S, Fearon EF, Wilson JKV, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 1990;249:912-915.
20. Tamura T, Aoyama N, Saya H, Haga H, Futami S, Miyamoto M, Koh T, Ariyasu T, Tachi M, Kasuga M, Takahashi R. Induction of Fas-mediated apoptosis in p53-transfected human colon carcinoma cells. Oncogene 1995;11:1939-1946.
21. Goldstein DJ, Weller SK. Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: Isolation and characterization of an ICP6 lacZ insertion mutant. J Virol 1988;62:196-205.
22. Kramm CM, Rainov NG, Sena-Esteves M, Chase M, Pechan PA, Chiocca EA, Breakefield XO. Herpes vector-mediated delivery of marker genes to disseminated central nervous system tumors. Hum Gene Ther 1996;7:291-300.
23. Rodrigues N, Rowan A, Smith ME, Kerr IB, Bodmer WF, Gannon JV, Lane DP. p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 1990;87:7555-7559.
24. Bischoff JR, Kim DH, Williams A, Heise C, Horn S, Muna M, Ng L, Nye JA, Sampson-Johannes A, Fattaey A, McCormick F. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 1996;274:373-376.
25. Breakefield XO, Kramm CM, Chiocca EA, Pechan PA. Herpes simplex virus vectors for tumor therapy. In Sobel RE, Scanlon KJ, eds. The Internet Book of Gene Therapy - Cancer Therapeutics. Hartford: Appleton & Lange, 1995, pp 41-56.